Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 mAb Therapies
- Posted by ISPE Boston
- On September 30, 2020
Eli Lilly and Amgen have entered into a global antibody manufacturing collaboration to significantly increase the supply capacity available for Lilly’s potential COVID-19 therapies. Lilly is currently studying several potential neutralizing antibodies for the prevention and/or treatment of COVID-19 as either monotherapy or in combination. Through this collaboration, the two companies will have the ability to quickly scale up […]
Read More